General MedicationsORALStandard
INVEGA
PALIPERIDONE
Standard Dose
12MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview INVEGA is listed in Drugs@FDA under application 022043 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient PALIPERIDONE Form and strength TABLET, EXTENDED RELEASE; ORAL - 12MG Sponsor JANSSEN LP Submission history Latest submission status date: 2007-04-27 00:00:00.
Structured Monograph
Clinical summary
Approval overview INVEGA is listed in Drugs@FDA under application 022043 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient PALIPERIDONE Form and strength TABLET, EXTENDED RELEASE; ORAL - 12MG Sponsor JANSSEN LP Submission history Latest submission status date: 2007-04-27 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.